PharmaBoardroom

How Can the Generics Industry Up its Game on Essential Medicine…

Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to…

Bill Sibold Swaps Sanofi for Biotech Seeking First NASH FDA…

After a 12-year stint at Sanofi, Bill Sibold is leaving Big Pharma to join the Pennsylvania-based biotech Madrigal Pharmaceuticals as CEO. Sibold, no…

Top Five Global CROs 2023

The global contract research organization (CRO) market is estimated to be worth USD 76.6 billion in 2023 and is projected to reach USD 127.3 billion…

Younes Lamarti – General Manager, Africa Global Logistics…

Younes Lamarti of Africa Global Logistics (AGL) explains the impact of the company's recent acquisition by MSC, the world's leading shipping line, how…

The Evolving Role of Medical Affairs in Pharma: Shaping the…

Mohamed Meshref M.D, PhD is a Professor of Oncology at Cairo University and Regional Medical Director at Boehringer Ingelheim for India, Middle East,…

Health at the UN General Assembly: Innovation & Equity for…

Ahead of the 78th session of the United Nations General Assembly (UNGA78), IFPMA Director General Thomas Cueni underscores the need for pandemic…

How Patent Analytics Can Show Pharma’s Top Performers

Patents can be an excellent way to demonstrate value, not only showing that a technology is protected but also how promising it can be when it…

New Illumina Boss Inherits Long List of Woes

Illumina’s newly appointed CEO, Jacob Thaysen, will take the reins of the gene sequencing giant at the end of September. Falling heir to the…

JLABS’ Global Head On Open Innovation & Writing…

Biotech and life sciences companies have a habit of clustering together, creating shared ecosystems to drive innovation. For going on 12 years Johnson…